LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

Home・Akciju saraksts・CorMedix Inc

CorMedix Inc

Slēgts

SektorsVeselības aprūpe

9.76 1.35

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

9.63

Max

9.77

Galvenie mērījumi
By Trading Economics
Ienākumi	89M 109M
Pārdošana	65M 104M
P/E Sektora vidējais	4.443 79.874
EPS	0.28
Peļņas marža	104.112
Darbinieki	64
EBITDA	37M 57M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+87.56% upside

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-94M 774M
Iepriekšējā atvēršanas cena	8.41
Iepriekšējā slēgšanas cena	9.76

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

9.2 / N/A Atbalsts un pretestība

CorMedix Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 28. nov. 15:29 UTC

Galvenie tirgus virzītāji

Iegādes, apvienošanās, pārņemšana

China's Jiangxi Copper Rejected by SolGold in $1 Billion Takeover Approach

2025. g. 28. nov. 21:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 28. nov. 19:59 UTC

Tirgus saruna

Oil Futures Settle Lower in Slow Black Friday Trade -- Market Talk

2025. g. 28. nov. 19:47 UTC

Tirgus saruna

U.S. Natural Gas Lifted By Cold Weather Outlook -- Market Talk

2025. g. 28. nov. 18:16 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 28. nov. 18:16 UTC

Tirgus saruna

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

2025. g. 28. nov. 18:08 UTC

Tirgus saruna

Market Talk Roundup: Latest on U.S. Politics

2025. g. 28. nov. 18:08 UTC

Tirgus saruna

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

2025. g. 28. nov. 17:48 UTC

Tirgus saruna

Bank of Canada May Revise Up Inflation Projections After GDP Data -- Market Talk

2025. g. 28. nov. 17:20 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 28. nov. 16:50 UTC

Iegādes, apvienošanās, pārņemšana

Week's Best: Sieg's Stature at Citi Grows -- Barrons.com

2025. g. 28. nov. 15:51 UTC

Tirgus saruna

Canada Household Spending Edges Lower -- Market Talk

2025. g. 28. nov. 15:33 UTC

Tirgus saruna

Crude Futures Gain as U.S. Market Reopens -- Market Talk

2025. g. 28. nov. 15:21 UTC

Tirgus saruna

Gold Rises on U.S. Rate-Cut Bets After CME Outage -- Market Talk

2025. g. 28. nov. 15:13 UTC

Tirgus saruna

Dollar Recovers Slightly as Investors Already Price in Fed Rate Cut -- Market Talk

2025. g. 28. nov. 15:11 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 28. nov. 15:11 UTC

Tirgus saruna

Canadian National Railway Showing Positive Trend Going Into 2026 -- Market Talk

2025. g. 28. nov. 14:51 UTC

Tirgus saruna

Canada GDP Report Masks Fragile State of Economy -- Market Talk

2025. g. 28. nov. 14:41 UTC

Tirgus saruna

Canada's GDP Level Pulled Higher by 'Eye-Opening' Revisions -- Market Talk

2025. g. 28. nov. 14:37 UTC

Tirgus saruna

U.S. Natural Gas Futures Rise As Temperatures Drop -- Market Talk

2025. g. 28. nov. 14:33 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 28. nov. 14:33 UTC

Tirgus saruna

Steep Import Drop Fuels Surprise Lift in Canada GDP -- Market Talk

2025. g. 28. nov. 14:20 UTC

Tirgus saruna

Too Much Noise in Canada's Surprise 3Q GDP Gain -- Market Talk

2025. g. 28. nov. 14:10 UTC

Tirgus saruna

Canadian Nowcast Came Closest to Predicting Surprise 3Q Strength -- Market Talk

2025. g. 28. nov. 13:39 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 28. nov. 13:39 UTC

Tirgus saruna

Canada Trade Data Could Face Larger-Than-Normal Revisions -- Market Talk

2025. g. 28. nov. 13:36 UTC

Tirgus saruna

Canada's Economy Expands More Than Expected -- Market Talk

2025. g. 28. nov. 13:29 UTC

Tirgus saruna

CME Outage Sowing Chaos Across Markets, Trade Nations Says -- Market Talk

2025. g. 28. nov. 13:27 UTC

Tirgus saruna

Russia-Ukraine Peace Efforts to Have Little Impact on Oil Fundamentals -- Market Talk

2025. g. 28. nov. 13:19 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

CorMedix Inc Prognoze

Cenas mērķis

By TipRanks

87.56% augšup

Prognoze 12 mēnešiem

Vidējais 18.4 USD 87.56%

Augstākais 22 USD

Zemākais 14 USD

Pamatojoties uz 7 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CorMedix Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

7 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 7 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam CorMedix Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

9.2 / N/AAtbalsts un pretestība

Recent bullish events outweigh bearish events.

All events are bullish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.